Department of Emergency Medicine, University Hospital Basel, Basel, Switzerland.
Department for General, Trauma and Reconstructive Surgery, Ludwig Maximilian University Munich, Munich, Germany.
J Am Geriatr Soc. 2020 May;68(5):977-982. doi: 10.1111/jgs.16400. Epub 2020 Mar 6.
BACKGROUND/OBJECTIVES: To determine the prevalence and severity of traumatic intracranial hemorrhage (tICH) in a large cohort of older adults presenting with low-energy falls and the association with anticoagulation or antiplatelet medication.
Bicentric retrospective cohort analysis.
Two level 1 trauma centers in Switzerland and Germany.
Consecutive sample of older adults (aged ≥65 y) presenting to the emergency department (ED) over a 1-year period with low-energy falls who received cranial computed tomography (cCT) within 48 hours of ED presentation.
The prevalence and severity of tICHs was assessed and the outcomes (in-hospital mortality, admission to intensive care unit [ICU], or neurosurgical intervention) were specified. We used multivariate regression models to measure the association between anticoagulation/antiplatelet therapy and the risk for tICH after adjustment for known predictors.
The overall prevalence for tICH detected by cCT was 176 of 2567 (6.9%). Neurosurgical intervention was performed in 15 of 176 (8.5%) patients with tICH, 28 of 176 (15.9%) patients were admitted to the ICU, and 14 of 176 (8.0%) died in the hospital. CT-detected skull fracture and signs of injury above the clavicles were the strongest predictors for the presence of tICH (odds ratio [OR] = 4.28; 95% confidence interval [CI] = 2.79-6.51; OR = 1.88; 95% CI = 1.3-2.73, respectively). Among 2567 included patients, 1424 (55%) were on anticoagulation/antiplatelet therapy. Multivariate regression models showed no differences for the risk of tICH (OR = 1.05; 95% CI = .76-1.47; P = .76) or association with the head-specific Injury Severity Scale (incident rate ratio = 1.08; 95% CI = .97-1.19; P = .15) with or without anticoagulation/antiplatelet therapy.
Medication with anticoagulants or antiplatelet agents was not associated with higher prevalence and severity of tICH in older patients with low-energy falls undergoing cCT examination. In addition to cCT-detected skull fractures, visible injuries above the clavicles were the strongest clinical predictors for tICH. Our findings merit prospective validation. J Am Geriatr Soc 68:977-982, 2020.
背景/目的:确定在大量因低能量跌倒而就诊的老年患者中,创伤性颅内出血(tICH)的发生率和严重程度,以及其与抗凝或抗血小板药物的相关性。
这是一项瑞士和德国 2 家 1 级创伤中心进行的回顾性、双中心队列分析。
连续入选了 1 年内因低能量跌倒而到急诊科就诊、在发病 48 小时内接受头颅计算机断层扫描(cCT)检查的年龄≥65 岁的老年患者。
评估 tICH 的发生率和严重程度,并明确(院内死亡率、入住重症监护病房[ICU]或神经外科干预)的结局。我们使用多变量回归模型,在调整已知预测因素后,测量抗凝/抗血小板治疗与 tICH 风险之间的相关性。
在 2567 例接受 cCT 检查的患者中,tICH 的总体发生率为 176 例(6.9%)。176 例 tICH 患者中有 15 例(8.5%)接受了神经外科干预,28 例(15.9%)患者入住 ICU,14 例(8.0%)患者院内死亡。CT 检测到的颅骨骨折和锁骨以上的损伤征象是存在 tICH 的最强预测因素(比值比[OR] = 4.28;95%置信区间[CI] = 2.79-6.51;OR = 1.88;95% CI = 1.3-2.73)。在 2567 例纳入患者中,1424 例(55%)正在接受抗凝/抗血小板治疗。多变量回归模型显示,tICH 风险(OR = 1.05;95% CI = 0.76-1.47;P = 0.76)或与头部特定损伤严重程度评分(发病率比[IRR] = 1.08;95% CI = 0.97-1.19;P = 0.15)之间无差异,无论是否使用抗凝/抗血小板治疗。
在接受 cCT 检查的因低能量跌倒而就诊的老年患者中,抗凝或抗血小板药物治疗与 tICH 的发生率和严重程度增加无关。除了 CT 检测到的颅骨骨折外,锁骨以上的可见损伤是 tICH 的最强临床预测因素。我们的研究结果值得进一步前瞻性验证。